T cells are our first line of defense against cancer, but the battle tends to exhaust them. Now, scientists have found a way ...
Strategies that use the body’s natural defence system to fight cancer, an approach known as immunotherapy, have already shown ...
By Pooja Toshniwal Paharia Sodium in tumor microenvironments found to heighten T-cell activation, suggesting new cancer ...
Due to the remarkable success of the Research Topic 'New Insights in Veterinary Cancer Immunology' and the rapidly evolving subject area, we are pleased to launch Volume II for this topic. The tumour ...
免疫衰老,即衰老相关的免疫功能下降是这些衰老相关疾病发病和死亡的重要原因之一。最近的研究表明,NK细胞是衰老细胞免疫监视的核心参与者,与其衰老相关的积累可促进衰老相关的慢性低度炎症的发生。
新药香雷糖足膏是全球III期临床试验研究中,唯一溃疡完全愈合率超过60%的DFU创新药,它可以通过抑制M1型巨噬细胞,活化M2型巨噬细胞,重塑创面微环境,使得M1/M2巨噬细胞达到平衡,从而促进创面愈合[4]。香雷糖足膏已于今年3月获得美国FDA授予 ...
AMMAN - The King Hussein Cancer Centre (KHCC) has announced a new medical breakthrough in cancer <a target=_blank href= ...
Vallina, from the CRIS Immuno-Oncology Unit, in Madrid (Spain), explains that a new approach provides 'trained troops' of ...
Pharmaceutical Technology on MSN10 天
T-cell targeting Candid Therapeutics launches with $370m
The new biotech has inherited two T cell engager antibodies as part of a three-way merger with Vignette and TRC 2004.